摘要
目的:研究重组人白细胞介素8(rhIL8)动员小鼠造血干/祖细胞的生物学效应。方法:将rhIL8单独或联合重组人粒细胞集落刺激因子(rhGCSF)给BALB/c小鼠静脉内注射,观察BALB/c小鼠外周血单个核细胞(PBMNC)的增殖能力;并将PBMNC回输给经致死性照射(7.5Gy60Coγ射线照射)的BALB/c小鼠,观察其造血重建功能。结果:每只小鼠单独注射rhIL830μg15分钟后,外周血中混合细胞集落形成单位(CFUMix)数量达峰值[(194±61)×103/L],比对照组[(7±3)×103/L]明显升高;外周血中ckit+Sca1+细胞为(3186±517)×103/L,亦比对照组[(644±341)×103/L]明显升高;联合注射rhGCSF则可使外周血CFUMix和ckit+Sca1+细胞分别增高至(790±48)×103/L和(10729±2339)×103/L。单独注射rhIL8后动员的PBMNC回输给致死性照射的BALB/c小鼠,其外周血中骨髓造血重建活性(MRA)细胞比对照组明显升高,联合rhGCSF组外周血中MRA细胞数可达(356.3±87.7)×1?
Objective: To study the mobilization effects of recombinant human IL 8(rhIL 8) on mouse peripheral blood hematopoietic progenitors (HPCs). Methods:A daily single dose of rhIL 8 was intravenously injected into normal or G CSF treated mice for two days. The number of colony forming unit Mix (CFU Mix) in peripheral blood was analyzed by colony assay, while the number of c kit +Sca 1 + HPCs was examined by immunofluorescence staining. In addition, colony forming unit of spleen (CFU S) and marrow repopulating ability (MRA) cells were examined by transplanting lethally irradiated mice. Results: Single dose of rhIL 8 (30μg) significantly increased the numbers of CFU Mix[(194±61)×10 3/L] and c kit + Sca 1 + cells [(3186±517)×10 3/L] in the peripheral blood as compared with that of normal saline controls [(7±3)×10 3/L and (644±341)×10 3/L] at 15 minutes after intravenous injection. G CSF could also increase peripheral CFU Mix and c kit + Sca 1 + cells to (790±48)×10 3/L and (10729±2339)×10 3/L, respectively, after subcutaneously injection for two days, this increase was further augmented by rhIL 8 injection. IL 8 alone or in combination with G CSF could significantly increase the number of CFU S and MRA cells in circulating blood. Conclusion: IL 8 alone or in combination with G CSF could significantly mobilize circulating HPCs.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
1998年第12期642-645,共4页
Chinese Journal of Hematology
基金
江苏省科委优秀青年教师基金
国防科工委基金
关键词
白细胞介素8
G-CSF
造血干细胞
造血干细胞移植
Interleukin 8 Granulocyte colony stimulating factor Hematopoietic stem cells Hematopoietic stem cell transplantation